KLRK1 and neoplasm: The results revealed that NKG2D CAR-T treatment significantly inhibit tumor growth in B-NDG mice as indicated by reduced tumor volume and tumor weight; and notably, pretreatment of mice with VPA further showed significant tumor growth inhibition (Figure 5B; Supplementary Figures S1C, D).